Literature DB >> 15780476

Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia.

M Shiote1, I Nagano, H Ilieva, T Murakami, H Narai, Y Ohta, T Nagata, M Shoji, K Abe.   

Abstract

Vascular endothelial growth factor (VEGF) is reported to play a neuroprotective role through a VEGF receptor, fetal liver kinase-1 (Flk-1) in vitro. We investigated whether reduction of Flk-1 could induce motor neuron loss in rat spinal cord by inhibiting the expression of Flk-1 in rat spinal cord using antisense oligodeoxynucleotides (ODNs) against the Flk-1 receptor. Rat spinal cord was repetitively exposed to 12% hypoxia, and the change of the phosphatidylinositol 3-kinase (PI3-K)/Akt pathway and the mitogen-activated protein kinase kinase (MEK)/extracellular-signal-regulated kinase (ERK) pathway was examined. Intrathecal infusion of Flk-1 antisense ODNs for 7 days suppressed almost completely Flk-1 expression in the lumbar segment of the spinal cord and was followed by a hypoxic challenge with 12% oxygen for 1 h that was repeated for 7 more days. In the lumbar segment, we observed that reduced Flk-1 expression and hypoxic challenge for 7 days resulted in approximately 50% loss of motor neurons, in which the activation of Akt and ERK, that is, increased levels of phosphorylated-Akt and of phosphorylated-ERK by hypoxia, was markedly inhibited. In contrast, the reduction of Flk-1 expression alone did not induce motor neuron loss. These results suggest that VEGF exerts its protective effect on motor neurons against hypoxia-induced toxicity by the Flk-1 receptor through the PI3-K/Akt and the MEK/ERK signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780476     DOI: 10.1016/j.neuroscience.2004.12.031

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS.

Authors:  C Moreau; D Devos; V Brunaud-Danel; L Defebvre; T Perez; A Destée; A B Tonnel; Ph Lassalle; N Just
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

2.  MicroRNA-185-5p: a marker of brain-sparing in foetuses with late-onset growth restriction.

Authors:  José Morales-Roselló; Gabriela Loscalzo; Eva María García-Lopez; José Santiago Ibañez Cabellos; José Luis García-Gimenez; Antonio José Cañada Martínez; Alfredo Perales Marín
Journal:  Epigenetics       Date:  2021-12-30       Impact factor: 4.861

3.  Signaling through the vascular endothelial growth factor receptor VEGFR-2 protects hippocampal neurons from mitochondrial dysfunction and oxidative stress.

Authors:  Tianfeng Hao; Patricia Rockwell
Journal:  Free Radic Biol Med       Date:  2013-05-31       Impact factor: 7.376

4.  The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy.

Authors:  Yousef H Aldebasi; Arshad H Rahmani; Amjad A Khan; Salah Mesalhy Aly
Journal:  Int J Clin Exp Med       Date:  2013-04-12

Review 5.  Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis.

Authors:  Ana Catarina Pronto-Laborinho; Susana Pinto; Mamede de Carvalho
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

6.  Extraocular motoneurons of the adult rat show higher levels of vascular endothelial growth factor and its receptor Flk-1 than other cranial motoneurons.

Authors:  Silvia Silva-Hucha; Rosendo G Hernández; Beatriz Benítez-Temiño; Ángel M Pastor; Rosa R de la Cruz; Sara Morcuende
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

Review 7.  Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System.

Authors:  Silvia Silva-Hucha; Angel M Pastor; Sara Morcuende
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

Review 8.  The role of VEGF receptors in angiogenesis; complex partnerships.

Authors:  S Cébe-Suarez; A Zehnder-Fjällman; K Ballmer-Hofer
Journal:  Cell Mol Life Sci       Date:  2006-03       Impact factor: 9.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.